Power Law company profile

Arvinas

Biotech & Life Sciences · New Haven, United States · Founded 2013 · IPO 2018 Unicorn

Pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases

Revenue

$263M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

13 investors on Arvinas's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Connecticut Innovations

Canaan

Elm Street Ventures

5AM Ventures

Series B+ 9 investors entered at this stage

Yale University

OrbiMed

Nextech Venture

Hillhouse Capital

Deerfield

New Leaf Venture Partners

Sirona Capital

RA Capital Management

Nextech Invest

Global footprint

Where Arvinas has talent and traffic

AI talent share

0.7% of workforce is AI talent
(2 of 307 staff)

Core AI10.33%

Other AI10.33%

Non-AI workforce30599.35%

Workforce by country

3 countries with
team presence

🇺🇸 United States99%

🇬🇧 United Kingdom0.7%

🇦🇹 Austria0.3%

3 countries shown

Web traffic by country

20K monthly visits
across markets

🇺🇸 United States51.5%

🇮🇳 India19.5%

🇬🇧 United Kingdom15%

🇨🇦 Canada7%

🇯🇵 Japan5.5%

Top 5 markets shown

Patent intelligence

$223M patent portfolio · 142 active families

Estimated portfolio value

$223M

3.5× smaller than top peer BioNTech ($780M)

142 active patent families

Where Arvinas innovates Molecular biologyTarget proteinDiseaseUbiquitin ligase bindingCereblon

Where Arvinas concentrates vs peers

Each axis is a top-10 topic across Arvinas and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Arvinas

An AI-synthesized read of the highest-engagement posts about Arvinas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arvinas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles